School of Pharmacy - News

The U.S. Food and Drug Administration, FDA, has granted research funding to too ocular drug projects.

For the first time ever, researchers used the transporter protein OATP1C1, which is found in the brain, to enhance drug delivery into the brain, and especially into glial cells.

UEF and partners received over 3.2 million euros in development funding from various instruments.

A recent visit to Ghana by a UEF delegation witnessed the signing of two memoranda of understanding on education and research collaboration.

In vitro and in vivo methodologies were employed to investigate ocular drug metabolism across species and ocular tissues.

Tetsuya Terasaki has opened a new research field of pharmacoproteomics, which is expected to play an important role in the progress of the pharmaceutical and biomedical sciences in the next decade.

Boosting virtual screening with machine learning allowed for a 10-fold time reduction in the processing of 1.56 billion drug-like molecules.

The Finnish Research Impact Foundation (FRIF) has granted 2.1 million euros of funding to joint research projects between universities and corporate partners.

The doctoral research covers preclinical studies performed to obtain the comprehensive pharmacokinetic parameters of two important ocular drugs: brinzolamide and dexamethasone.

Beta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).